Skip to main content
Complete Genomics logo

Complete Genomics

2.7

A Complete Genomics Company

www.completegenomics.com
Location
San Jose, CA
Size
201-500 employees
Revenue
Unknown / Non-Applicable
Industry
Biotechnology Research
Founded
2005

Pioneering Genomic Sequencing Innovation

Complete Genomics stands at the forefront of biotechnology research, driving genomic breakthroughs that improve lives worldwide. Founded in 2005 and headquartered in San Jose, California, this privately held life sciences company has spent nearly two decades developing cutting-edge high-throughput sequencing technology. With 201-500 employees, Complete Genomics combines scientific excellence with customer-focused innovation to advance healthcare solutions globally.

Comprehensive End To End Genomic Solutions

As a global leader in next-generation sequencing (NGS), Complete Genomics offers a complete product portfolio spanning the entire genomic workflow:

  • Sample extraction and library preparation systems
  • Advanced lab automation equipment
  • DNBSEQ sequencing instruments ranging from low to extra-high throughput
  • Sophisticated data analysis platforms
  • Full-spectrum genetic sequencing instruments accelerating scientific breakthroughs

Innovation Driven Work Environment

Complete Genomics fosters a proactive, problem-solving culture where collaborative cross-functional teams tackle emerging challenges in genomics. Employees work in a customer-focused environment emphasizing empathy, service excellence, and scientific rigor. The company's San Jose demonstration laboratory serves as both an innovation hub and customer experience center, where team members showcase advanced technologies while building trusted partnerships with researchers.

Career Growth and Professional Development

The organization invests in employee success through:

  • Hands-on training in cutting-edge sequencing and analysis tools
  • Professional development opportunities in emerging biotechnology fields
  • Flexible work arrangements combining on-site collaboration and remote flexibility
  • Travel opportunities for conferences, customer sites, and scientific presentations
  • Dynamic team environments supporting continuous learning

Competitive Benefits and Work Life Balance

Complete Genomics demonstrates commitment to employee wellness through comprehensive benefits including medical, dental, and vision coverage, 401(k) retirement plans, and unique perks like gym membership reimbursements and employee discount programs. Team members enjoy 20 PTO days, 11 holidays annually, and education assistance programs supporting long-term career development in the rapidly evolving genomics industry.

Mission

To drive genomics forward with complete sequencing solutions that improve lives through pioneering high-throughput sequencing technology and innovation.

Frequently Asked Questions

Jobs for Complete Genomics in United States

1 results

  • Complete Genomics
    Complete Genomics

    $130K/yr - $180K/yr
    95199 San Jose, CA

Complete Genomics and SOPHiA GENETICS Announce Integration of MSK-IMPACT® and MSK-ACCESS® Assays on DNBSEQ-T1+ Platform at AMP 2025

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (Nasdaq: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS(R) and MSK-IMPACT(R) powered with SOPHiA DDM(TM) on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy and solid tumor applications to...

Read Full Article

Complete Genomics Highlights Clinical Research Sequencing Solutions and Partnerships at AMP 2025

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing technologies, will showcase its expanded portfolio for oncology and infectious disease research at the 2025 Association for Molecular Pathology (AMP) Annual Meeting, Nov. 11-15 in Boston. Located at Booth 1210 at AMP, Complete Genomics will highlight its DNBSEQ sequencing platforms and collaborations with leading assay developers and clinical laboratories, underscoring how its technology...

Read Full Article

SOPHiA GENETICS and Complete Genomics Integrate Sequencing and AI Analytics to Accelerate Adoption of Precision Medicine

BOSTON, Nov. 11, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a collaboration with SOPHiA GENETICS (NASDAQ: SOPH), a global leader in AI-driven precision medicine, to launch and co-market MSK-ACCESS(R) and MSK-IMPACT(R) powered with SOPHiA DDM(TM) on Complete Genomics' DNBSEQ-T1+ sequencing platform. The companies aim to broaden access to precision oncology testing by offering the best-in-class liquid biopsy and solid tumor applications to...

Read Full Article

Complete Genomics Highlights New Products, Partnerships, First DNBSEQ User Group Meeting at ASHG 2025

BOSTON, Oct. 14, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced a series of milestones at the American Society of Human Genetics (ASHG) Annual Meeting, Oct. 14-18, 2025 in Boston. At ASHG 2025, for the first time, Complete Genomics will host a DNBSEQ(TM) User Group Meeting to bring together researchers and customers to share best practices, explore applications across oncology, rare disease and population genomics, and hear updates from the...

Read Full Article

Complete Genomics announces Gene by Gene as its newest sequencing service provider at ASHG

BOSTON, Oct. 13, 2025 /PRNewswire/ -- Complete Genomics, a leading innovator in genomic sequencing, today announced at the American Society of Human Genetics Annual Meeting that it has added Houston-based Gene by Gene, a leading genetics laboratory, to its Sequencing Service Provider Program. The Complete Genomics Service Provider Program connects its customers to a network of service providers, offering access to high-quality sequencing services using Complete Genomics DNBSEQ(TM) sequencing...

Read Full Article